This is a non-core endpoint: only basic statistics are computed.
Injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
DM_EYE_OPER_VEGF_INJECT_VITR
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Operations: NOMESCO codes
^CKD05
1 out of 7 registries used, show all original rules.
6463
Check minimum number of events None
6463
Include endpoints None
6463
Remove individuals based on genotype QC
6268
DM_EYE_OPER_VEGF_INJECT_VITR
Control definitions
Control exclude
DM_EYE_OPER
Extra metadata
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
based on the number of shared cases.
Broader endpoints:
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any ICDMAIN event in hilmo or causes of death
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 6268 | 3034 | 3234 |
| Unadjusted prevalence (%) | 1.66 | 1.44 | 1.94 |
| Mean age at first event (years) | 69.90 | 70.62 | 69.23 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: DM_EYE_OPER_VEGF_INJECT_VITR – Injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Injection of anti-VEGF-antibody or corticosteroid or any drug into vitreous body
↥Endpoint not on priority list, no data to show.